Return to site
Return to site

InBrain Pharma announces the completion of its DIVE-I phase I/II clinical trial in Parkinson's disease

InBrain Pharma, a biotech specialized in brain infusion of drugs for neurological disorder management, today announced the completion of its DIVE-I phase I/II clinical trial, which began in September 2020. More information

 

PreviousNext
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
Necessary Cookies
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
Analytics Cookies
These cookies help us better understand how visitors interact with our website and help us discover errors.
Preferences Cookies
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save